Gabather AB receives initial EEG data analysis from the GT-002 target engagement study
Gabather AB ( www.gabather.com) has received the electroencephalography (EEG) analysis of the 17 human healthy volunteers involved in the target engagement study with the lead clinical candidate GT-002 as part of the collaboration with MINDIG . The quantitative analysis of the recordings showed statistically significant increase induced by GT-002 on the EEG alpha frequency band power. MINDIG will continue the EEG data analysis and expects to deliver new analysis of the data early next year. “ The EEG data analysis shows that our drug candidate GT-002 ,